about
Targeting leukocyte integrins in human diseasesSmall-molecule inhibitors of protein-protein interactions: progressing towards the dreamA small molecule inhibitor of alpha4 integrin-dependent cell migration.Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists.Conformational mAb as a tool for integrin ligand discoverySouth African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication.5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists.Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotidesLeukocyte integrins and their ligand interactions.Role of integrin alpha4 in drug resistance of leukemiaThe role of integrin antagonists in the treatment of inflammatory bowel disease.Products for the treatment of inflammatory bowel disease: a patent review (2013 - 2014).Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis.Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects.Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.Dysferlin regulates cell adhesion in human monocytes.Dehydro-β-proline Containing α4β1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay.Conformationally tailored N-[(2-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl)carbonyl]proline templates as molecular tools for the design of peptidomimetics. Design and synthesis of fibrinogen receptor antagonists.Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites.Current Anti-Integrin Therapy for Ocular Disease.Suppression of acute experimental allergic encephalomyelitis with a small molecule inhibitor of alpha4 integrin.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
P2860
Q28293910-84FC3C13-07A0-4C5E-B330-6DE25AEDCF99Q29617758-E419770B-DE4E-4438-9670-F0ACD7804279Q33323130-C6195175-2794-4B6D-8591-A69C01E729B3Q33763221-F8CB2AB1-FD18-429E-A79A-DE9A1AD7A90BQ34987342-E39B9CB2-97C8-4F83-A395-118B62897671Q35672336-3B33CF36-1CF3-49E3-88E3-6DC028F08101Q35714170-4A4C5919-F58B-4ED2-8F6C-ED3F2535604EQ36445393-87343CA9-902E-4914-876E-99BBC585FC4FQ37015817-E485BAF0-A302-4025-828A-F1EE34E3247FQ37382190-3E0CB0EB-D839-4684-B69E-B428EAAA513CQ38218126-3FF17856-322C-48B0-96FB-80876880DB33Q38257410-5FDA76EE-BAC6-44E6-AFDA-F826D3F43730Q38461139-BE1273EC-B4D2-41D4-BDB8-C4901CD768CEQ38650245-D898E2BC-6E97-4EF6-9B96-BB7E4F28ABE7Q38700087-EA2A4E6E-AA4F-4B1B-8EAF-0A4EE3507159Q40444924-C4E078FF-3D62-46C0-BBF3-605A9D7B5B77Q40466907-7B85CF2A-10AD-4E8B-A56B-8C3BC2209BF1Q40776035-B6AA8A6C-1748-450A-978B-6B254F72D948Q42430716-9E87D031-D259-4358-8DA8-9D9C51992721Q44891338-442FE86D-7650-45BF-BB6C-694729B34467Q46640400-BBDCF464-E181-4D26-9742-A46C9318C64FQ46667235-A8935F78-2AAC-4403-9849-37342CC46843Q47311682-FF1BD9B3-9C92-48C1-BFF1-88F8A2F7F412Q48095233-CA8E83E5-4F00-4090-9015-9EA6534D3037Q51830169-7A92FF5D-A828-427B-812C-CDB8D123805CQ55340253-E097AB2F-96FC-42A3-947B-71B380C81712Q57751823-55B7989E-6E13-4BE0-814B-48584C6064E5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Alpha 4 integrin antagonists.
@ast
Alpha 4 integrin antagonists.
@en
type
label
Alpha 4 integrin antagonists.
@ast
Alpha 4 integrin antagonists.
@en
prefLabel
Alpha 4 integrin antagonists.
@ast
Alpha 4 integrin antagonists.
@en
P356
P1476
Alpha 4 integrin antagonists.
@en
P2093
David Y Jackson
P304
P356
10.2174/1381612023394737
P577
2002-01-01T00:00:00Z